Traps inflammation : These cells grab inflammatory “pain chemicals” right in the joint, stopping pain signals before they hit your brain.
Repairs damage : They release healing factors to protect and regrow cartilage, unlike steroids that speed up joint wear.
Safe & non-addictive : Fully mature cells mean no cancer risk, and zero opioid haze – perfect for long-term relief. Dr. Gabsang Lee, a Johns Hopkins prof and SereNeuro co-founder, calls it a sponge for pain factors. Preclinical tests at ISSCR showed it halts cartilage loss and eases chronic OA pain. No more limping after a weekend match! Why India Needs This Now In our pain clinics, we see it daily: Cricketers with bowler’s knee, runners with hip woes, swimmers with shoulder pains, aunties with stair-climbing pain. Opioids fuel India’s addiction crisis, and PRP shots (which you might already offer) help but don’t always stop degeneration.
SN101 stands out : Beats single-target drugs by handling all pain pathways at once. Safer than cortisone jabs that harm joints over time. A step toward disease-modifying OA drugs (DMOAD) – fix the root, not just symptoms. Mayo Clinic expert Dr. Daniël Saris says it preserves joints without addiction risk. Backed by Maryland funding, SereNeuro is gearing up for human trials. Could this land in Indian trials soon, maybe via Regenexx affiliates? Real Hope for Indian Patients
Picture this : A 50-year-old badminton champ in Telangana gets SN101. Weeks later, he’s back on court, cartilage rebuilding, no pills needed. For pain docs like us at Indo British Advanced Pain Clinic, it’s exciting—blends neuromodulation, regenerative medicine, and ultrasound-guided precision we love. SereNeuro’s pipeline targets chronic pain head-on. Watch this space: Indian studies are next. Ready to ditch OA pain? Stay tuned for updates on regenerative breakthroughs. Share your joint story below—let’s chat non-opioid futures!
Sources : ISSCR Symposium data via SereNeuro Therapeutics. Always consult your pain specialist.
